246 related articles for article (PubMed ID: 28938963)
1. Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome.
Kaushal S; Wehman B; Pietris N; Naughton C; Bentzen SM; Bigham G; Mishra R; Sharma S; Vricella L; Everett AD; Deatrick KB; Huang S; Mehta H; Ravekes WA; Hibino N; Difede DL; Khan A; Hare JM
Am Heart J; 2017 Oct; 192():48-56. PubMed ID: 28938963
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.
Ishigami S; Ohtsuki S; Tarui S; Ousaka D; Eitoku T; Kondo M; Okuyama M; Kobayashi J; Baba K; Arai S; Kawabata T; Yoshizumi K; Tateishi A; Kuroko Y; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
Circ Res; 2015 Feb; 116(4):653-64. PubMed ID: 25403163
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections.
Burkhart HM; Qureshi MY; Rossano JW; Cantero Peral S; O'Leary PW; Hathcock M; Kremers W; Nelson TJ;
J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1614-1623. PubMed ID: 31345560
[TBL] [Abstract][Full Text] [Related]
5. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
Greene SJ; Epstein SE; Kim RJ; Quyyumi AA; Cole RT; Anderson AS; Wilcox JE; Skopicki HA; Sikora S; Verkh L; Tankovich NI; Gheorghiade M; Butler J
J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):283-290. PubMed ID: 26479144
[TBL] [Abstract][Full Text] [Related]
7. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial.
Tarui S; Ishigami S; Ousaka D; Kasahara S; Ohtsuki S; Sano S; Oh H
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1198-1207, 1208.e1-2. PubMed ID: 26232942
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells improve cardiac function and left ventricular remodeling in a heart transplantation model.
Montanari S; Dayan V; Yannarelli G; Billia F; Viswanathan S; Connelly KA; Keating A
J Heart Lung Transplant; 2015 Nov; 34(11):1481-8. PubMed ID: 26234284
[TBL] [Abstract][Full Text] [Related]
9. Autologous Cardiac Stem Cell Injection in Patients with Hypoplastic Left Heart Syndrome (CHILD Study).
Kaushal S; Hare JM; Shah AM; Pietris NP; Bettencourt JL; Piller LB; Khan A; Snyder A; Boyd RM; Abdullah M; Mishra R; Sharma S; Slesnick TC; Si MS; Chai PJ; Davis BR; Lai D; Davis ME; Mahle WT
Pediatr Cardiol; 2022 Oct; 43(7):1481-1493. PubMed ID: 35394149
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.
Trachtenberg B; Velazquez DL; Williams AR; McNiece I; Fishman J; Nguyen K; Rouy D; Altman P; Schwarz R; Mendizabal A; Oskouei B; Byrnes J; Soto V; Tracy M; Zambrano JP; Heldman AW; Hare JM
Am Heart J; 2011 Mar; 161(3):487-93. PubMed ID: 21392602
[TBL] [Abstract][Full Text] [Related]
11. Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial.
Kaushal S; Hare JM; Hoffman JR; Boyd RM; Ramdas KN; Pietris N; Kutty S; Tweddell JS; Husain SA; Menon SC; Lambert LM; Danford DA; Kligerman SJ; Hibino N; Korutla L; Vallabhajosyula P; Campbell MJ; Khan A; Naioti E; Yousefi K; Mehranfard D; McClain-Moss L; Oliva AA; Davis ME
Eur Heart J Open; 2023 Mar; 3(2):oead002. PubMed ID: 36950450
[TBL] [Abstract][Full Text] [Related]
12. Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.
Guijarro D; Lebrin M; Lairez O; Bourin P; Piriou N; Pozzo J; Lande G; Berry M; Le Tourneau T; Cussac D; Sensebe L; Gross F; Lamirault G; Huynh A; Manrique A; Ruidavet JB; Elbaz M; Trochu JN; Parini A; Kramer S; Galinier M; Lemarchand P; Roncalli J
Int J Cardiol; 2016 Apr; 209():258-65. PubMed ID: 26901787
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.
Butler J; Epstein SE; Greene SJ; Quyyumi AA; Sikora S; Kim RJ; Anderson AS; Wilcox JE; Tankovich NI; Lipinski MJ; Ko YA; Margulies KB; Cole RT; Skopicki HA; Gheorghiade M
Circ Res; 2017 Jan; 120(2):332-340. PubMed ID: 27856497
[TBL] [Abstract][Full Text] [Related]
14. Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study.
Elabd C; Centeno CJ; Schultz JR; Lutz G; Ichim T; Silva FJ
J Transl Med; 2016 Sep; 14(1):253. PubMed ID: 27585696
[TBL] [Abstract][Full Text] [Related]
15. Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial.
Noriega DC; Ardura F; Hernández-Ramajo R; Martín-Ferrero MÁ; Sánchez-Lite I; Toribio B; Alberca M; García V; Moraleda JM; Sánchez A; García-Sancho J
Transplantation; 2017 Aug; 101(8):1945-1951. PubMed ID: 27661661
[TBL] [Abstract][Full Text] [Related]
16. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.
Reinders ME; Dreyer GJ; Bank JR; Roelofs H; Heidt S; Roelen DL; Zandvliet ML; Huurman VA; Fibbe WE; van Kooten C; Claas FH; Rabelink TJ; de Fijter JW
J Transl Med; 2015 Nov; 13():344. PubMed ID: 26537851
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of tricuspid regurgitation in patients with hypoplastic left heart syndrome undergoing tricuspid valvuloplasty.
Bautista-Hernandez V; Brown DW; Loyola H; Myers PO; Borisuk M; del Nido PJ; Baird CW
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):832-8; discussion 838-40. PubMed ID: 25129586
[TBL] [Abstract][Full Text] [Related]
18. Impaired power output and cardiac index with hypoplastic left heart syndrome: a magnetic resonance imaging study.
Sundareswaran KS; Kanter KR; Kitajima HD; Krishnankutty R; Sabatier JF; Parks WJ; Sharma S; Yoganathan AP; Fogel M
Ann Thorac Surg; 2006 Oct; 82(4):1267-75; discussion 1275-7. PubMed ID: 16996919
[TBL] [Abstract][Full Text] [Related]
19. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.
Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246
[TBL] [Abstract][Full Text] [Related]
20. Hypoplastic left heart syndrome.
Connor JA; Thiagarajan R
Orphanet J Rare Dis; 2007 May; 2():23. PubMed ID: 17498282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
